Handelsbanken Fonder AB raised its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 12.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 72,713 shares of the real estate investment trust's stock after acquiring an additional 7,800 shares during the period. Handelsbanken Fonder AB's holdings in Omega Healthcare Investors were worth $2,752,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Daiwa Securities Group Inc. raised its holdings in Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock worth $160,739,000 after buying an additional 3,003,845 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Omega Healthcare Investors by 328.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust's stock worth $67,642,000 after acquiring an additional 1,274,238 shares during the last quarter. FMR LLC lifted its position in Omega Healthcare Investors by 9.9% in the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust's stock valued at $171,625,000 after acquiring an additional 380,626 shares in the last quarter. Franklin Resources Inc. boosted its stake in Omega Healthcare Investors by 441.4% during the 3rd quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust's stock valued at $17,177,000 after purchasing an additional 350,570 shares during the last quarter. Finally, Parallax Volatility Advisers L.P. increased its holdings in shares of Omega Healthcare Investors by 115.9% in the 3rd quarter. Parallax Volatility Advisers L.P. now owns 34,982 shares of the real estate investment trust's stock worth $1,424,000 after purchasing an additional 254,471 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
OHI has been the topic of a number of research analyst reports. BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Royal Bank of Canada lifted their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a research note on Monday, November 11th. BMO Capital Markets raised shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price objective for the company in a report on Monday, December 9th. Mizuho raised their target price on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a report on Thursday, December 5th. Finally, JMP Securities reaffirmed a "market perform" rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Omega Healthcare Investors presently has a consensus rating of "Moderate Buy" and a consensus price target of $41.67.
Check Out Our Latest Report on Omega Healthcare Investors
Omega Healthcare Investors Stock Performance
NYSE OHI traded up $0.03 on Friday, hitting $36.87. 3,265,145 shares of the company traded hands, compared to its average volume of 1,638,392. The business's 50 day moving average price is $37.23 and its 200-day moving average price is $39.02. Omega Healthcare Investors, Inc. has a 52-week low of $29.66 and a 52-week high of $44.42. The company has a current ratio of 7.07, a quick ratio of 7.07 and a debt-to-equity ratio of 1.02. The company has a market capitalization of $10.39 billion, a price-to-earnings ratio of 23.79, a P/E/G ratio of 1.09 and a beta of 0.99.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share for the quarter, beating analysts' consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. Equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.
Omega Healthcare Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, February 10th. This represents a $2.68 annualized dividend and a dividend yield of 7.27%. Omega Healthcare Investors's payout ratio is 172.90%.
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Articles

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.